Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer
Abstract OVO-like protein 1 (OVOL1) has been implicated in the progression of various human cancers; however, the prognostic and immunological significance, as well as its biological role in pancreatic cancer, are unknown. In this study, by analyzing multiple patient cohorts, OVOL1 was found to be e...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-13196-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849342967223943168 |
|---|---|
| author | Jinping Li Zhenyan Deng Zhaofang Yan Shuxian Huang Jiamin Jin Chichu Xie Jinfeng Gan |
| author_facet | Jinping Li Zhenyan Deng Zhaofang Yan Shuxian Huang Jiamin Jin Chichu Xie Jinfeng Gan |
| author_sort | Jinping Li |
| collection | DOAJ |
| description | Abstract OVO-like protein 1 (OVOL1) has been implicated in the progression of various human cancers; however, the prognostic and immunological significance, as well as its biological role in pancreatic cancer, are unknown. In this study, by analyzing multiple patient cohorts, OVOL1 was found to be elevated in pancreatic cancer, which was associated with poor overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI). Two nomogram survival models for predicting 1-, 2-, and 3-year OS and DSS with excellent accuracy were constructed, respectively. Tumors with elevated OVOL1 expression showed decreased immune cell infiltration, including CD8 T cells, NK cells, and cytotoxic cells, and increased tumor mutation burden (TMB). Enrichment analysis revealed that OVOL1 was related to various biological terms and signaling pathways. Knockdown of OVOL1 reduced the proliferation of pancreatic cancer cells and inhibited the ERK/JNK/p38 MAPK signaling pathway. Furthermore, OVOL1 was revealed to be hypomethylated in pancreatic cancer, with low levels of OVOL1 methylation predicting poor outcomes. Our findings suggest that upregulation of OVOL1 has prognostic value and is associated with the unfavorable immune microenvironment in pancreatic cancer. OVOL1 is crucial for pancreatic cancer cell proliferation, which could be attributed to its effect on the ERK/JNK/p38 MAPK signaling pathway. |
| format | Article |
| id | doaj-art-2e8d8088e75c4b1594dbf79d8865b918 |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-2e8d8088e75c4b1594dbf79d8865b9182025-08-20T03:43:11ZengNature PortfolioScientific Reports2045-23222025-07-0115111410.1038/s41598-025-13196-9Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancerJinping Li0Zhenyan Deng1Zhaofang Yan2Shuxian Huang3Jiamin Jin4Chichu Xie5Jinfeng Gan6Department of Histology and Embryology, School of Preclinical Medicine, Guilin Medical UniversityDepartment of Clinical Laboratory, Guilin Hospital of the Second Xiangya Hospital of Central South UniversityGuangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical UniversityGuangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical UniversityGuangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical UniversityGuangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical UniversityGuangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical UniversityAbstract OVO-like protein 1 (OVOL1) has been implicated in the progression of various human cancers; however, the prognostic and immunological significance, as well as its biological role in pancreatic cancer, are unknown. In this study, by analyzing multiple patient cohorts, OVOL1 was found to be elevated in pancreatic cancer, which was associated with poor overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI). Two nomogram survival models for predicting 1-, 2-, and 3-year OS and DSS with excellent accuracy were constructed, respectively. Tumors with elevated OVOL1 expression showed decreased immune cell infiltration, including CD8 T cells, NK cells, and cytotoxic cells, and increased tumor mutation burden (TMB). Enrichment analysis revealed that OVOL1 was related to various biological terms and signaling pathways. Knockdown of OVOL1 reduced the proliferation of pancreatic cancer cells and inhibited the ERK/JNK/p38 MAPK signaling pathway. Furthermore, OVOL1 was revealed to be hypomethylated in pancreatic cancer, with low levels of OVOL1 methylation predicting poor outcomes. Our findings suggest that upregulation of OVOL1 has prognostic value and is associated with the unfavorable immune microenvironment in pancreatic cancer. OVOL1 is crucial for pancreatic cancer cell proliferation, which could be attributed to its effect on the ERK/JNK/p38 MAPK signaling pathway.https://doi.org/10.1038/s41598-025-13196-9OVOL1Pancreatic cancerPrognosisImmune microenvironmentProliferationMAPK signaling pathway |
| spellingShingle | Jinping Li Zhenyan Deng Zhaofang Yan Shuxian Huang Jiamin Jin Chichu Xie Jinfeng Gan Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer Scientific Reports OVOL1 Pancreatic cancer Prognosis Immune microenvironment Proliferation MAPK signaling pathway |
| title | Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer |
| title_full | Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer |
| title_fullStr | Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer |
| title_full_unstemmed | Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer |
| title_short | Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer |
| title_sort | unveiling the impact of ovol1 on prognosis immune microenvironment and proliferation in pancreatic cancer |
| topic | OVOL1 Pancreatic cancer Prognosis Immune microenvironment Proliferation MAPK signaling pathway |
| url | https://doi.org/10.1038/s41598-025-13196-9 |
| work_keys_str_mv | AT jinpingli unveilingtheimpactofovol1onprognosisimmunemicroenvironmentandproliferationinpancreaticcancer AT zhenyandeng unveilingtheimpactofovol1onprognosisimmunemicroenvironmentandproliferationinpancreaticcancer AT zhaofangyan unveilingtheimpactofovol1onprognosisimmunemicroenvironmentandproliferationinpancreaticcancer AT shuxianhuang unveilingtheimpactofovol1onprognosisimmunemicroenvironmentandproliferationinpancreaticcancer AT jiaminjin unveilingtheimpactofovol1onprognosisimmunemicroenvironmentandproliferationinpancreaticcancer AT chichuxie unveilingtheimpactofovol1onprognosisimmunemicroenvironmentandproliferationinpancreaticcancer AT jinfenggan unveilingtheimpactofovol1onprognosisimmunemicroenvironmentandproliferationinpancreaticcancer |